Blog
The Bioeconomy Has Arrived

The Bioeconomy Has Arrived

The outbreak of COVID-19 is fueling an urgent need for discovery and development, particularly around medicine, testing and materials – all highly dependent on biology. Many private organizations and government agencies are working together, and teams of scientists across borders are breaking their culture of secrecy and competitive advantage to partner up, openly sharing data to solve major problems fast.

read more
Advancing the Pace of New Material Discovery

Advancing the Pace of New Material Discovery

By merging enEvolv’s powerful platform technology with our existing genome engineering, automation and machine learning capabilities, we will dramatically improve our ability to discover, design and commercialize breakthrough biologically-manufactured products.

read more
Welcome to Our New Board Members

Welcome to Our New Board Members

At Zymergen, we use biology to create never-before imagined materials. As we continue to scale and build our growing pipeline of next generation products, we’re proud to announce that we’ve appointed Jay Flatley, Chairman of the Board of Illumina, and Sandra E. Peterson, former Group Worldwide Chairman for Johnson & Johnson, to Zymergen’s Board of Directors. Jay will serve as Lead Independent Director.

read more